Sitemap
Pages
- Immunoassay
- Mass Spectrometry
- Environmental Sustainability
- ELISpot
- Radiopharmaceutical Bioanalysis
- Genomics
- Proteomics
- Contact
- Why Join Synexa
- Opportunities
- Kimberg Internship
- Immuno Oncology
- Biosimilars
- Autoimmune
- Vaccines
- Why Synexa
- Flow Cytometry
- Tissue Imaging & Cell Solutions
- Biomarker Consulting
- Bioanalysis
- Biomarker- Solutions
- Synexa Team
- Translational
- Solutions for Clinical Research
- About
- Thank you
- Events
- Sitemap
- Terms of use
- Cookie-policy
- Privacy
- Webinars
- News
- Careers
- Therapeutic Expertise
- Home
- Operations
- Pharmacokinetics
- Bioanalytical Science
- Leadership
Blog Articles
- From Pathways to Proof: Targeted Phosphoproteomics and PTM Analysis with LC-MS/MS
- Establishing Biosimilarity: Regulatory and Scientific Expectations
- Why The Future Of Precision Medicine Will Be Defined By The Quality And Strategy Of Biomarker Signatures
- Radiopharmaceutical Drug Development: A Bioanalytical Lab Perspective
- Building a bioanalytical workflow for a vaccine study: The key assays and considerations
- Quantitative Analysis of Oligonucleotides: An out of the box LC-MS/MS approach
- The Next Frontier for CAR T-Cell Therapy: Shifting Gears to Autoimmune Conditions
- Identifying biomarkers of success: Integrated bioanalysis for glioblastoma CAR-T cell clinical trials
- Allogeneic CAR T cell therapies: A major step forward
- A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology
- The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers
- The STING in the tail: How our own defense mechanisms to infection may be working against us
- Falling drug approval rates: What should we be doing differently?
- Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer
- World Multiple Sclerosis Day 2024: Wider access to crucial antibody therapies
- World Preeclampsia Day 2024: A spotlight on the neurological consequences
- Primary Immunodeficiency Week: The promise of gene therapy
- Primary Immunodeficiency Week: A complex landscape of genetic disorders
- From Pottiphar to Potts: Skeletal TB from Ancient Egypt to the Present Day
- Bridging the Gap: Translating Animal Model Findings to Clinical Oncology Breakthroughs
- Cardiovascular complications in chronic kidney disease: New biomarkers and treatment
- Modelling Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A rare autoimmune disease
- World Cancer Day 2024: Closing the gap
- Mycobacterium leprae: The lazy cousin to TuberculosisÂ
- The criticality of early detection of pre-eclampsia: New biomarkers
- Top 3 Biotech Trends in 2024 | Dr. Caroline BeltranÂ
- Top 3 Biotech Trends in 2024 | Dr. Nicholas Woudberg
- Bioanalytical Strategies for Cell Therapy Clinical Trials
- AI-assisted pathology for precision medicine: Are we there yet?
- Uncovering tissue complexity through spatial biology
- The standardization of synuclein seed amplification assays
- Biomarkers in saliva: A novel approach to endometriosis
- Revolutionizing Lung Cancer Treatment with CAR-T Cell Therapy
- Advances in Autoimmune Hepatitis Biomarkers: Improving Diagnosis and Treatment Outcomes
- Liquid biopsies: a non-invasive picture of cancer physiology
- Challenges and Opportunities: Development of the HIV vaccine
- Biomarkers for Dementia
- Asthma Care for All
- Monitoring Immune Response in Pediatric Vaccine Recipients
- Improving the World's First Malaria Vaccine
- Parkinson’s Disease Biomarker Assessment: New Approaches and Directions
- The Current State of Tuberculosis Research | World TB Day
- How Cytokine Release Assays Work in Predictive Immunotoxicology
- Understanding the Role of Phenotypic Assays in Drug Research
- What Biomarkers Are Used For CNS Drug Development?
- How Immunogenomics Factors into Cell and Gene Studies
- Using Exosomes As Clinical Biomarkers
- A Brief Introduction To Novel Modalities
- Enhancing PCR Molecular Diagnostics Using Immunoassays
- How to Measure Bacteriophages in Clinical Studies for Antimicrobial Agents
- How to Accelerate Pre-Clinical Trials with Flow Cytometry
- What are Immune Checkpoint Inhibitors?
- Where Does Bioanalysis Fit into Drug Discovery Pipelines?
- A Quick Guide to Biomarker Solutions
- Fibrosis and SMAD signalling
- Lipids as Biomarkers of Brain Disorders
- Synexa raises awareness for Rare Diseases Day
- The Biomarker Association between Depression and Vascular Disease
- Infertility and the importance of the endometrial immune balance
- Th17 Cells and IL-17: a possible link between inflammation and neuronal decline in Multiple Sclerosis
- Spot on: Use of Dried Blood Spots (DBS) for serological immunoassays
- Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain
- The prospect of immunotherapy for combating Alzheimer’s disease
- Rapid expansion of Treg cells protects from collateral colitis following a viral trigger
- Immune biomarkers in depression
- Faecal Calprotectin as a biomarker in Crohn’s disease
- Immune checkpoint inhibitors and MDSCs
- Potential concussion biomarkers discovered in circulating blood after brain injury
- Complement C4 Genes and Sex-Biased Disease Susceptibility
- A unifying expression signature for SLE
Feature Articles
- Behind the wave
- Immunogenicity 101: Antidrug Antibodies, Neutralizing Antibodies, and everything in between
- NanoString nCounter Technology – COVID-19 Immunological and Inflammatory Response
- SARS CoV-2: when does the calm become the perfect storm?
- Lack of implantation of an embryo: when the numbers count
Brochures
Datasheets
webinars
- Overcoming Challenges in ELISpot Method Development and Validation to Support Clinical Trials
- Radiopharmaceutical Bioanalysis Solutions
- Autoimmune Biomarker Profiling: Over a Decade of Experience in Lupus
- Key Insights for Biosimilar Method Development and Validation
- The Human Touch; patient-derived data from Synexa Prototrials®
- Persistence is key: Bioanalytical Strategies for Cell Therapy Clinical Trials
- Enhancing Flow Cytometry Precision and Accuracy in Immuno-Oncology Studies
- Accelerating TB Vaccine Development: Insights from Microsampling, Biomarkers and Data Analysis
News
- Synexa Life Sciences Achieves Gyrolab CRO Certification
- Synexa Life Sciences Partners with Waters to Trial Xevo TQ Absolute XR Mass Spectrometer
- Claire Wildgoose Appointed General Manager of Synexa Life Sciences – UK
- Synexa Life Sciences Achieves Highest Level My Green Lab Certification, Reinforcing Commitment to Lab Sustainability
- Sally Hannam Strengthens Synexa’s Scientific Expertise as Scientific Director
- Paul Holme joins the Synexa Global Management Team as Chief Operating Officer
- Synexa Life Sciences Expands Bioanalysis Capabilities with the Acquisition of CRO Alderley Analytical
- Synexa Life Sciences Enrols in My Green Lab Certification Program
- Announcing the 2024 Kimberg Internship Program: Nurturing the Next Generation of Scientific Leaders
- Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform
- Synexa Life Sciences hosts German Parliamentary Sub-Committee on Global Health at Cape Town laboratories
- Synexa Life Sciences Joins CEPI in Advancing Global Epidemic Preparedness and Response
- Synexa Life Sciences celebrates its 20th anniversary
- Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions
- Synexa Life Sciences expands operations in North America with new Rockville laboratory site
- Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities
- Synexa Life Sciences announces strategic growth plans and strengthening of its executive team
- Synexa Life Sciences Co-founder and CEO to become company’s Chairman
- Synexa Announces Tripartite Collaboration
